Diagnosis is the first step on the path to treatment and the foundation of disease control and prevention. As William Osler, sometimes described as the father of modern medicine, said in 1892: “There are three phases to treatment: diagnosis, diagnosis and diagnosis.”
Diagnostic tests guide clinical decision-making. By helping to ensure the use of appropriate treatments, diagnostics improve the efficiency of health care spending, and help us to fight antimicrobial resistance by guiding the appropriate use of antibiotics.
Diagnostic tests are also the foundation of disease surveillance and elimination.
About us - Vision & mission
FIND (Foundation for Innovative New Diagnostics) is an international non-profit organization that enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola, Lassa fever, and others.
FIND acts as a bridge between experts in technology development, policy, and clinical care, reducing barriers to innovation and effective implementation of diagnostic solutions in low- and middle-income countries.
A WHO Collaborating Centre, FIND works with more than 200 academic, industry, governmental, and civil society partners worldwide on over 70 active projects that cross six priority disease areas. FIND also has active collaborations with bilateral and multilateral organizations and clinical trial sites.
Since its inception in 2003, FIND has partnered in the delivery of 21 new diagnostic tools used in 150 LMICs, including ten for tuberculosis. Over 50 million FIND-supported products have been provided to our target markets since the start of 2015. FIND has created an enabling environment for numerous other products through the provision of specimen banks, reagent development, and better market visibility.
We are committed to a future in which diagnostics underpin treatment decisions and provide the foundation for disease surveillance, control, and prevention.FIND’s work in these areas reflects a willingness to address market entry barriers for diagnostics globally.
We also support the appropriate use of diagnostics in many countries through training programmes, quality assurance programmes, and laboratory strengthening work.
Developing a new diagnostic test is only the first step on the path to a diagnostic solution.
Creating value in global public health depends on the transformation of innovative ideas into tangible changes. New diagnostic tests need help to have the greatest possible impact on the health of communities.
At FIND, we focus on providing diagnostic solutions to maximise the health impact of diagnostic tests: linking affordable, easy-to-use tests with effective treatment and with disease surveillance, control and elimination efforts.
Diagnostic solutions are holistic–they include tests that are proven to meet priority medical needs, accompanied by a suite of actions that improve access to and use of those tests.
Such solutions simplify diagnosis for patients, clinicians and national health programmes. They include the means for connectivity, to enable the use of mobile technology for rapid delivery of test results. And they enable more efficient health-care spending.
Four strategic pillars guide our creation of diagnostic solutions:
1. Catalyse development: Identify needed diagnostic solutions and remove barriers to their development
2. Guide use & inform policy: Lead products through the clinical trials pathway to global policy on use and market entry
3. Accelerate access: Support uptake and appropriate use of diagnostics to achieve health impact
4. Shape agenda: Improve understanding of the value of diagnostics and strengthen commitment to their funding and use